1 Lhuillier F, "comparison of desflurane isoflurane and halothane in rabbit myocardium" 486-91, 2002
2 Cope DK, "Volatile anaesthetics protect the ischemic rabit myocardium from infarction" 86 : 699-709, 1997
3 Li YW, "The transient nature of the effect of ischemic preconditioning on myocardial infarct size and ventricular arrhythmia" 123 : 346-53, 1992
4 Steenbergen C, "The role of p38 mitogen-activated protein kinase in myocardial ischemia/reperfusion injury:relationship to ischemic preconditioning" 97 : 276-85, 2002
5 Krenz M, "The protective and anti- protective effects of ethanol in a myocardial infarct model" 103-14, 2002
6 Grover GJ, "The ATP- Sensitive potassium channel blocker glibenclamide does not abolish preconditioning in isolated ischemic rat hearts" 265 : 559-64, 1993
7 Toller WG, "Sevoflurane reduces myocardial infarct size and decreases the time threshold for ischemic preconditioning in dogs" 1999
8 Novalija E, "Sevoflurane mimics ischemic preconditioning effects on coronary flow and nitric oxide release in isolated hearts" 91 : 701-12, 1999
9 Varadarajan SG, "Sevoflurane before or after ischemia improves contractile and metabolic function while reducing myoplasmic Ca(2+)loading in intact hearts" 96 : 125-33, 2002
10 Wall TM, "Role of bradykinin in myocardial preconditioning" 25 : 524-30, 1995
1 Lhuillier F, "comparison of desflurane isoflurane and halothane in rabbit myocardium" 486-91, 2002
2 Cope DK, "Volatile anaesthetics protect the ischemic rabit myocardium from infarction" 86 : 699-709, 1997
3 Li YW, "The transient nature of the effect of ischemic preconditioning on myocardial infarct size and ventricular arrhythmia" 123 : 346-53, 1992
4 Steenbergen C, "The role of p38 mitogen-activated protein kinase in myocardial ischemia/reperfusion injury:relationship to ischemic preconditioning" 97 : 276-85, 2002
5 Krenz M, "The protective and anti- protective effects of ethanol in a myocardial infarct model" 103-14, 2002
6 Grover GJ, "The ATP- Sensitive potassium channel blocker glibenclamide does not abolish preconditioning in isolated ischemic rat hearts" 265 : 559-64, 1993
7 Toller WG, "Sevoflurane reduces myocardial infarct size and decreases the time threshold for ischemic preconditioning in dogs" 1999
8 Novalija E, "Sevoflurane mimics ischemic preconditioning effects on coronary flow and nitric oxide release in isolated hearts" 91 : 701-12, 1999
9 Varadarajan SG, "Sevoflurane before or after ischemia improves contractile and metabolic function while reducing myoplasmic Ca(2+)loading in intact hearts" 96 : 125-33, 2002
10 Wall TM, "Role of bradykinin in myocardial preconditioning" 25 : 524-30, 1995
11 Curtis MJ, "Reperfusion induced arrythmias are critically dependent upon occluded zone size:relevance to the mechanism of arrythmogenesis" 21 : 625-37, 1989
12 Baines CP, "Protein tyrosine kinase is downstream of protein kinase C for ischemic preconditioning's anti-infarct effect in the rabbit heart" 30 : 383-92, 1998
13 Speechly-Dick ME, "Protein kinase C:its role in ischemic preconditioning In the rat" 75 : 586-90, 1994
14 Vegh A, "Protective effects of preconditioning ischemic myocardium involve cyclo-oxygenase products" 24 : 1020-3, 1990
15 Zhou FW, "Protection of calcitonin gene-related peptide-mediated preconditioning against coronary endotheial dysfunction induced by reperfusion in the isolated rat heart" 64 : 1091-7, 1999
16 Liu GS, "Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart" 84 : 350-6, 1991
17 Murry CE, "Preconditioning with ischemia:a delay of lethal cell injury in ischemic myocardium" 74 : 1124-36, 1986
18 Flack JE, "Preconditioning the heart by repeated stunning improves myocardial salvage" 5-74, circulation1991
19 DeFily DV, "Preconditioning protects coronary arteriolar endothelium from ischemia-reperfusion injury" 265 : -6, 1993
20 Shiki K, "Preconditioning of ischemic myocardium:reperfusion induced arrhythmias" 153 : -6, 1987
21 Cohen MV, "Preconditioning cause improved wall motion as well as smaller infarcts after transient coronary occlusion in rabbits" 84 : 341-9, 1991
22 Weinbrenner C, "Phosphorylation of tyrosine 182 of p38 mitogen-activated protein kinase correlates with the protection of preconditioning in the rabbit heart" 29 : 2383-91, 1997
23 Preckel B, "Myocardial protection by volatile anesthetics" 27 : 116-23, 2002
24 Kato R, "Myocardial protection by anesthetic agents against ischemia-reperfusion injury:an update for anesthesiologists" 49 : 777-91, 2002
25 Okubo S, "Myocardial preconditioning:basic concepts and potential mechanisms" 196 : 3-12, 1999
26 Schultz JE, "Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart" 78 : 1100-4, 1996
27 Bouchard JF, "Mechanisms of protection afforded by preconditioning to endothelial function against ischemic injury" 5-, 1996
28 Ismaeil MS, "Mechanisms of isoflurane-induced myocardial preconditioning in rabbits" 90 : 812-21, 1999
29 Tanaka K, "Mechanism of preconditioning by isoflurane in rabbits:a direct role for reactive oxygen species" 97 : 1485-90, 2002
30 Toombs CF, "Limitation of infarct size in the rabbit by ischemic preconditioning is reversible with glibenclamide" 27 : 617-22, 1993
31 Kersten JR, "Isoflurane mimics ischemic preconditioning via activation of K ATP channels reduction of myocardial infarct size with an acute memory phase" 361-70, 1997
32 Murry CE, "Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode" 66 : 913-31, 1990
33 Schott RJ, "Ischemic preconditioning reduces infarct size in swine myocardium" 66 : 1133-42, 1990
34 Liu Y, "Ischemic preconditioning protects against infarction in rat heart" 263 : -12, 1992
35 Richard V, "Ischemic preconditioning protects against coronary endothelial dysfunction induced by ischemia and reperfusion" 89 : 1254-61, 1994
36 Giannella E, "Ischemic preconditioning prevents the impairment of hypoxic coronary vasodilation caused by ischemia/reperfusion" 81 : 415-22, 1997
37 Cave AC, "Ischemic preconditioning and contractile function:studies with normothermic and hypothermic global ischemia" 24 : 1113-23, 1992
38 Hein TW, "Ischemia-reperfusion selectively impairs nitric oxide- mediated dilation in coronary arterioles:counteracting role of arginase" 17 : 2328-30, 2003
39 Bueno OF, "Improvement of extracellular signal- regulated kinases 1/2 in cardiac hypertrophy and cell death" 91 : 776-81, 2002
40 Cribier A, "Improved myocardial ischemic response and enhanced collateral circulation with long repetitive coronary occlusion during angioplasty:a prospective study" 20 : 578-86, 1992
41 Kersten JR, "Glyburide,a KATP channel antagonist,attenuates the cardioprortective effects of isoflurane in stunned myocardium" 83 : 27-33, 1996
42 Reimer KA, "Four brief periods of myocardial ischemia cause no cumulative ATP loss or necrosis" 251 : -15, 1986
43 Volovsek A, "Effects of duration of ischemia during preconditioning on mechanical function,enzyme release and energy production in the isolated working rat heart" 24 : 1011-9, 1992
44 Hagar JM, "Effect of preconditioning ischemia on reperfusion arrythmias after coronary artery occlusion and reperfusion in the rat" 68 : 61-8, 1991
45 Speechly-Dick ME, "Does ischemic preconditioning in the human involve protein kinase C and the ATP-dependent K+ channel Studies of contractile function after simulated ischemia in an atrial in vitro model" 1030-5, 1995
46 Hassanabad ZF, "Coronary endothelial dysfunction increases the severity fo ischemia- induced ventricular arrhythmias in rat isolated perfused hearts" 93 : 241-9, 1998
47 Stowe DF, "Cardiac preconditioning by volatile anesthetic agents:a defining role for altered mitochondrial bioenergetics" 6 : 439-48, 2004
48 Gross GH, "Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs" 70 : 223-33, 1992